Literature DB >> 1372022

Linear epitope mapping of an Sm B/B' polypeptide.

J A James1, J B Harley.   

Abstract

Autoantibodies binding the Sm B/B' peptides are commonly associated with SLE. IgG antibodies binding overlapping octapeptides of Sm B/B' have been evaluated in 10 patients with anti-Sm and anti-nRNP precipitins, 5 patients with other autoimmune serology, and 4 normal human sera. Neither normal controls nor patients without an anti-Sm precipitin significantly bind any of the Sm B/B' octapeptides. All sera tested containing an anti-Sm precipitin strongly bind octapeptides from eight regions of the Sm B/B' sequence. Three of these eight regions share the same octapeptide sequences (PPPGMRPP) that are consistently the most immunoreactive octapeptides from Sm B/B'. Binding of the similar PPPGIRGP, as well as binding to deletion and substitution peptides, suggest that the motif PPPG(I,M) (R,K) appears to best define this binding. Interestingly, PAPGMRPP in the nRNP C peptide is as antigenic as PPPGMRPP and may provide a partial explanation for the cross-reactivity shown between Sm and nRNP autoantibodies. However, the sequence, PPPGMIPP, from nRNP A is not antigenic. These data define the linear sequence autoantigenicity of the Sm B/B' protein. They also demonstrate that the predominant autoimmune epitope is a proline-rich sequence from which limited variance is permitted before antigenicity is destroyed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372022

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

Review 2.  Evolving story of autoantibodies in systemic lupus erythematosus.

Authors:  David S Pisetsky
Journal:  J Autoimmun       Date:  2019-12-04       Impact factor: 7.094

3.  An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.

Authors:  J A James; K M Kaufman; A D Farris; E Taylor-Albert; T J Lehman; J B Harley
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

4.  Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.

Authors:  Bahar Artım Esen; Gülden Yılmaz; Sami Uzun; Melda Ozdamar; Alper Aksözek; Sevil Kamalı; Salih Türkoğlu; Ahmet Gül; Lale Ocal; Orhan Aral; Murat Inanç
Journal:  Rheumatol Int       Date:  2010-07-27       Impact factor: 2.631

5.  Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.

Authors:  Marwa Shehab; Nour Sherri; Hadi Hussein; Noor Salloum; Elias A Rahal
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

6.  60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.

Authors:  Latisha D Heinlen; Micah T McClain; Lauren L Ritterhouse; Benjamin F Bruner; Colin C Edgerton; Michael P Keith; Judith A James; John B Harley
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.

Authors:  Shan-Fu Yu; Huei-Chuin Wu; Wen-Chan Tsai; Jeng-Hsien Yen; Wen Chiang; Chung-Yee Yuo; Sheng-Nan Lu; Lien-Chai Chiang; Chung-Jen Chen
Journal:  Med Microbiol Immunol       Date:  2004-09-17       Impact factor: 3.402

8.  Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments.

Authors:  Brian D Poole; Timothy Gross; Shannon Maier; John B Harley; Judith A James
Journal:  J Autoimmun       Date:  2008-10-11       Impact factor: 7.094

9.  Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.

Authors:  Brian D Poole; Rebecca I Schneider; Joel M Guthridge; Cathy A Velte; Morris Reichlin; John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2009-03

10.  Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies.

Authors:  J A James; M J Mamula; J B Harley
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.